Genfit S.a. ( GNFTF) - Key Metrics
GNFTF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.42 | -$0.52 | $0.07 | $0.06 |
| 2025Q4 | $0.64 | -$1.52 | $0.10 | $0.09 |
| 2025Q2 | $0.71 | -$0.20 | -$0.60 | -$0.63 |
| 2024Q4 | $0.12 | -$0.58 | $0.54 | $0.54 |
| 2024Q2 | $1.23 | $0.61 | -$0.23 | -$0.24 |
GNFTF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.52 |
| 2025Q4 | 0% | -0.84 |
| 2025Q2 | 0% | -3.75 |
| 2024Q4 | 0% | -1.47 |
| 2024Q2 | 0% | 2.11 |
GNFTF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.59% | 0% |
| 2025Q4 | 1.84% | 0% |
| 2025Q2 | -20.84% | 0% |
| 2024Q4 | 15.72% | 0% |
| 2024Q2 | -4.66% | 0% |
GNFTF
Price: $15.75
52 week price:
Earnings Per Share: -1.96 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 789.0 million